In cancer, Rab23 has been found to be highly expressed in carcinoma cells and is closely related to tumor cell proliferation, migration and apoptosis as an oncogene with tumor‐promoting activity, which makes it a useful cancer biomarker and potential therapeutic target.9, 10, 11, 12, 13, 14. This evidence concerns the gene RAB23 and cancer.